Ginkgo Bioworks Holdings, Inc. (DNA)

8.5 USD-11.55%close 2026-11-16Healthcare
Gurus hold3popularity #406 of 1982
Net buying (quarter)−$7.5M1 buying · 1 selling
Market Cap$471.4M52 Week Range: 5.48 – 14.98
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -5.64
The live quote provider is unreachable; the last known close is shown.

Ginkgo Bioworks Holdings, Inc. (DNA) is not among the 30 most-held stocks of the tracked superinvestor set. Price 8.50 USD; market cap $471.4M.

Guru Ownership

Popularity rank#406 of 1,982 securities
gurus hold it3
Net activity this quarter−$7.5M

Guru count: the consensus-panel funds (wide books such as Citadel or Renaissance excluded) holding the stock at quarter end; the header and the history table use the same definition.

What changed this quarter
$1.2M · 1 new buys · 0 added $8.7M · 1 reduced · 0 sold out1 net buyers · 1 net sellers
Top 5 by conviction
Viking Global Investors0.1%Reduced -18.9%
Baillie Gifford0.0%Unchanged 0.0%
Polen Capital Management0.0%New
Top 5 by value
Viking Global Investors$37.2MReduced -18.9%
Baillie Gifford$30.7MUnchanged 0.0%
Polen Capital Management$1.2MNew
Ownership by quarter · 72 funds with stored history
Report forgurus hold itTotal ValueAvg Weight
2024-09-302$33.0M0.1%
2024-12-312$37.0M0.1%
2025-03-312$21.5M0.1%
2025-06-302$41.9M0.1%
2025-09-302$54.3M0.1%
2025-12-312$31.0M0.1%
2026-03-311$21.9M0.1%
2026-06-301$35.4M0.1%
2026-09-303$69.0M0.1%

Price & valuation

Prev Close9.61
Open—
Day Range—
52 Week Range5.48 – 14.98
Volume—
Avg Volume (3M)—
Market Cap$471.4MSEC 10-K, 12/31/2025
BetaVolatility vs the market. Above 1: swings harder than the index.2.852 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-K, 12/31/2025
EPS (TTM)Annual net profit per share.-5.64SEC 10-K, 12/31/2025
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own DNA?

Ginkgo Bioworks Holdings, Inc. (DNA) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on DNA bullish or bearish?

DNA is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.